Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Crippa

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Future Oncology (London, England)|December 21, 2012
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinomaEster Orlandi, Stefano Tomatis, Paolo Potepan, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
Cancer|September 17, 2004
Imatinib mesylate in chordomaPaolo G Casali, Antonella Messina, Silvia Stacchiotti, et al.
Investigational New Drugs|February 14, 2016
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancerAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
Annals of Surgical Oncology|June 24, 2016
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network DatabaseSilvia Stacchiotti, Salvatore Provenzano, Gianpaolo Dagrada, et al.
The Lancet. Oncology|July 24, 2012
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trialAndrea Necchi, Luigi Mariani, Nadia Zaffaroni, et al.
Clinical Genitourinary Cancer|May 3, 2014
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinomaPatrizia Giannatempo, Alessandra Alessi, Rosalba Miceli, et al.
Clinical Genitourinary Cancer|April 24, 2016
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy FailureAndrea Necchi, Andrea Anichini, Daniele Raggi, et al.
AJR. American Journal of Roentgenology|June 24, 2003
A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findingsBruno Damascelli, Gian Luigi Patelli, Rodolfo Lanocita, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Future Oncology (London, England)|December 21, 2012
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinomaEster Orlandi, Stefano Tomatis, Paolo Potepan, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
Cancer|September 17, 2004
Imatinib mesylate in chordomaPaolo G Casali, Antonella Messina, Silvia Stacchiotti, et al.
Investigational New Drugs|February 14, 2016
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancerAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
Annals of Surgical Oncology|June 24, 2016
Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network DatabaseSilvia Stacchiotti, Salvatore Provenzano, Gianpaolo Dagrada, et al.
The Lancet. Oncology|July 24, 2012
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trialAndrea Necchi, Luigi Mariani, Nadia Zaffaroni, et al.
Clinical Genitourinary Cancer|May 3, 2014
Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinomaPatrizia Giannatempo, Alessandra Alessi, Rosalba Miceli, et al.
Clinical Genitourinary Cancer|April 24, 2016
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy FailureAndrea Necchi, Andrea Anichini, Daniele Raggi, et al.
AJR. American Journal of Roentgenology|June 24, 2003
A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findingsBruno Damascelli, Gian Luigi Patelli, Rodolfo Lanocita, et al.
Pageof 4